We are live on
!
Find out more
DMKJ
David M. Knott Jr Portfolio holdings
AUM
$189M
Turnover
22.11%
1-Year Est. Return
67.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.86%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
(-0.21%)
Cap. Flow
-$5.96M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19
Avg Time Held Equity + Options
0.5
years
Top 10 Avg Time Held Equity + Options
0.7
years
Top 20 Avg Time Held Equity + Options
0.6
years
Avg Time Held Equity only
0.5
years
Top 10 Avg Time Held Equity only
0.7
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Codexis
CDXS
|
+$1.79M |
| 2 |
GSK
GSK
|
+$1.52M |
| 3 |
FTAI Infrastructure
FIP
|
+$1.21M |
| 4 |
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
|
+$1.01M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$920K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$3.65M |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
+$3.07M |
| 3 |
Incyte
INCY
|
+$2.04M |
| 4 |
Innoviva
INVA
|
+$1.7M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.63% |
| 2 | Materials | 25.45% |
| 3 | Miscellaneous | 11.79% |
| 4 | Financials | 10.86% |
| 5 | Real Estate | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Calumet Specialty Products
CLMT
$5.06B
| $55.4M | 23.31% |
4,325,000
| – | – |
2021 Q4
3 quarters
|
|
2
DocGo
DCGO
$26.9M
| $13.9M | 5.84% |
1,400,000
| – | – |
2021 Q4
3 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$4.2T
| $10.8M | 4.54% |
112,220
| – | – |
2021 Q4
3 quarters
|
|
4
Apollo Global Management
APO
$67B
| $10.5M | 4.4% |
225,000
| – | – |
2021 Q4
3 quarters
|
|
5
Ligand Pharmaceuticals
LGND
$5.88B
| $9.9M | 4.17% |
184,345
| – | – |
2021 Q4
3 quarters
|
|
6
Franklin BSP Realty Trust
FBRT
$500M
| $9.25M | 3.89% |
859,047
| – | – |
2021 Q4
3 quarters
|
|
7
FTAI Aviation
FTAI
$16.8B
| $6.37M | 2.68% |
425,000
-72,675
| -15% | -$1.25M |
2021 Q4
3 quarters
|
|
8
Pfizer
PFE
$166B
| $6.28M | 2.64% |
143,500
| – | – |
2021 Q4
3 quarters
|
|
9
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
| $5.69M | 2.4% |
495,000
| – | – |
2021 Q4
3 quarters
|
|
|
AGAC.WS
10
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
| $5.18M | 2.18% |
450,750
| – | – |
2021 Q4
3 quarters
|
|
|
MDWT
11
DELISTED
Midwest Holding Inc. Common Stock
MDWT
| $5.16M | 2.17% |
390,241
+36,304
| +10% | +$497K |
2021 Q4
3 quarters
|
|
12
Vertex Pharmaceuticals
VRTX
$126B
| $4.92M | 2.07% |
17,000
| – | – |
2021 Q4
3 quarters
|
|
13
Johnson & Johnson
JNJ
$612B
| $4.05M | 1.7% |
24,800
| – | – |
2021 Q4
3 quarters
|
|
|
CTIC
14
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.3M | 1.39% |
566,687
| – | – |
2021 Q4
3 quarters
|
|
|
EIGR
15
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.08M | 1.3% |
13,643
| – | – |
2021 Q4
3 quarters
|
|
16
Jazz Pharmaceuticals
JAZZ
$13.6B
| $2.99M | 1.26% |
22,411
| – | – |
2021 Q4
3 quarters
|
|
|
GLHAW
17
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
| $2.88M | 1.21% |
250,000
| – | – |
2021 Q4
3 quarters
|
|
18
DELISTED
Kennedy-Wilson Holdings
KW
| $2.71M | 1.14% |
175,000
| – | – |
2021 Q4
3 quarters
|
|
|
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.69M | 1.13% |
43,490
| – | – |
2021 Q4
3 quarters
|
|
20
AbbVie
ABBV
$501B
| $2.69M | 1.13% |
20,037
| – | – |
2021 Q4
3 quarters
|
|
21
Xenon Pharmaceuticals
XENE
$3.28B
| $2.15M | 0.9% |
59,500
| – | – |
2021 Q4
3 quarters
|
|
22
JPMorgan Chase
JPM
$890B
| $2.13M | 0.9% |
20,385
| – | – |
2021 Q4
3 quarters
|
|
23
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$124M
| $2.12M | 0.89% |
6,250
| – | – |
2022 Q1
2 quarters
|
|
24
Merck
MRK
$364B
| $2.11M | 0.89% |
24,500
| – | – |
2021 Q4
3 quarters
|
|
|
MSAC
25
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $1.98M | 0.83% |
200,000
| – | – |
2022 Q2
1 quarter
|
|
Similar funds
SCA
FI
MFS
FRA
CAM
BAG
SHC
HC
David M. Knott Jr's Q3 2022 Portfolio in Review
As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Materials and Miscellaneous.
- David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
- David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
- David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
- David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
- David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
- David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
- David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.
Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.